Clinical Cardiology - Cleveland Clinic

May 6, 2022/Digestive

Cardiac Considerations for the Liver Transplant Patient

As the demographics of transplant recipients shift, their heart care must keep pace

22-HVI-2769712_hyptertrophic-cardiomyopathy_650x450

April 5, 2022/Heart, Vascular and Thoracic/Clinical Cardiology

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

22-HVI-2713173_spontaneous-coronary-artery-dissection_650x450

February 18, 2022/Heart, Vascular and Thoracic/Clinical Cardiology

Spontaneous Coronary Artery Dissection: Principles of Management

How Cleveland Clinic approaches the condition in the absence of randomized trial data

21-HVI-2500367-hypertrophic-cardiomyopathy-650×450

November 18, 2021/Heart, Vascular and Thoracic/Clinical Cardiology

In Obstructive Hypertrophic Cardiomyopathy, One Size Does Not Fit All

Why we favor a tailored approach to relieve LVOT obstruction

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

21-HVI-2360358-cardiogenic-shock-team-650×450

November 5, 2021/Heart, Vascular and Thoracic/Clinical Cardiology

Circulatory Support in Cardiogenic Shock: Weaning Is Just as Important as Initiation

Long-overdue guidance now available on readiness to wean and device explant

21-HVI-2460008-cardiac-virtual-visits-650×450

November 2, 2021/COVID-19

5 Steps to Swiftly Transform a Large Community Cardiology Practice to Virtual Visits

A snapshot of our multisite experience in safely maintaining care during COVID-19

21-HVI-2288859-COVID-19-and-the-heart_650x450

August 18, 2021/COVID-19

Canakinumab for COVID-19 With Cardiac Injury: Early Trial Shapes Strategy for Future Investigation

Three C Study suggests 28-day efficacy window, 600-mg dose

August 2, 2021/Heart, Vascular and Thoracic/Clinical Cardiology

Study Uncovers Serious Shortcomings of Systematic Reviews in Top Cardiology Journals

Nearly three-quarters found lacking in methodological quality and/or reporting practices

21-HVI-2140459 cardiac-telemetry_650x450

May 28, 2021/COVID-19

Cardiac Telemetry Validated as an Accurate Method of Continuous QTc Monitoring in Pandemic Conditions

Study supports telemetry as “no touch” alternative to 12-lead ECG

21-HVI-2168309-CQD-Cardiac-Surveillance-anti-HER2-Chemo

May 26, 2021/Heart, Vascular and Thoracic/Clinical Cardiology

Cardiac Surveillance for Anti-HER2 Chemotherapy: The Case for a More-Focused Approach

Recent data call for revisiting FDA surveillance recommendations